E. Mackay

1.8k total citations · 1 hit paper
23 papers, 1.4k citations indexed

About

E. Mackay is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, E. Mackay has authored 23 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 5 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in E. Mackay's work include Prostate Cancer Treatment and Research (5 papers), Diabetes and associated disorders (3 papers) and Cardiomyopathy and Myosin Studies (3 papers). E. Mackay is often cited by papers focused on Prostate Cancer Treatment and Research (5 papers), Diabetes and associated disorders (3 papers) and Cardiomyopathy and Myosin Studies (3 papers). E. Mackay collaborates with scholars based in United Kingdom, United States and Nigeria. E. Mackay's co-authors include Gian Franco Bottazzo, Peter G.F. Swift, B.M. Dean, D. R. Gamble, E. Oluwabunmi Olapade‐Olaopa, T R Terry, D. P. S. SANDHU, J F Mayberry, David K. Moscatello and Jonathan C. Banks and has published in prestigious journals such as New England Journal of Medicine, Gut and British Journal of Cancer.

In The Last Decade

E. Mackay

23 papers receiving 1.3k citations

Hit Papers

In Situ Characterization of Autoimmune Phenomena and Expr... 1985 2026 1998 2012 1985 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Mackay United Kingdom 14 634 491 375 367 275 23 1.4k
Alaa Afify United States 22 152 0.2× 230 0.5× 205 0.5× 164 0.4× 249 0.9× 57 1.5k
Irena Kirman United States 20 284 0.4× 267 0.5× 557 1.5× 61 0.2× 151 0.5× 50 1.3k
Fujitsugu Matsubara Japan 21 127 0.2× 428 0.9× 102 0.3× 341 0.9× 271 1.0× 83 1.3k
Olli Helminen Finland 20 195 0.3× 497 1.0× 255 0.7× 180 0.5× 319 1.2× 90 1.1k
Ricardo Giscombe Sweden 23 323 0.5× 130 0.3× 1.1k 2.8× 89 0.2× 301 1.1× 41 1.7k
Pierina Richiusa Italy 17 252 0.4× 214 0.4× 340 0.9× 461 1.3× 42 0.2× 44 1.3k
I. Tatarsky Israel 21 156 0.2× 92 0.2× 171 0.5× 201 0.5× 147 0.5× 94 1.6k
Hendrik Bergert Germany 18 220 0.3× 561 1.1× 126 0.3× 80 0.2× 264 1.0× 44 1.8k
Kathy L. Sivils United States 21 325 0.5× 390 0.8× 532 1.4× 130 0.4× 41 0.1× 49 1.8k
Kenneth E. Drazan United States 23 441 0.7× 615 1.3× 124 0.3× 48 0.1× 149 0.5× 30 1.5k

Countries citing papers authored by E. Mackay

Since Specialization
Citations

This map shows the geographic impact of E. Mackay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Mackay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Mackay more than expected).

Fields of papers citing papers by E. Mackay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Mackay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Mackay. The network helps show where E. Mackay may publish in the future.

Co-authorship network of co-authors of E. Mackay

This figure shows the co-authorship network connecting the top 25 collaborators of E. Mackay. A scholar is included among the top collaborators of E. Mackay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Mackay. E. Mackay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Olapade‐Olaopa, E. Oluwabunmi, David K. Moscatello, E. Mackay, et al.. (2007). A variant epidermal growth factor receptor protein is similarly expressed in benign hyperplastic and carcinomatous prostatic tissue in balck and white men. West African Journal of Medicine. 26(1). 42–7. 2 indexed citations
2.
Olapade‐Olaopa, E. Oluwabunmi, et al.. (2004). Androgen receptor protein expression in prostatic tissues in black and caucasian men. The Prostate. 59(4). 460–468. 22 indexed citations
3.
Olapade‐Olaopa, E. Oluwabunmi, David K. Moscatello, E. Mackay, et al.. (2004). Alterations in the expression of androgen receptor, wild type-epidermal growth factor receptor and a mutant epidermal growth factor receptor in human prostate cancer.. PubMed. 33(3). 245–53. 6 indexed citations
4.
Olapade‐Olaopa, E. Oluwabunmi, Olufemi J. Ogunbiyi, E. Mackay, et al.. (2001). Further Characterization of Storage-Related Alterations in Immunoreactivity of Archival Tissue Sections and its Implications for Collaborative Multicenter Immunohistochemical Studies. Applied immunohistochemistry & molecular morphology. 9(3). 261–266. 22 indexed citations
5.
Olapade‐Olaopa, E. Oluwabunmi, Olufemi J. Ogunbiyi, E. Mackay, et al.. (2001). . Applied Immunohistochemistry. 9(3). 261–266. 4 indexed citations
6.
Olapade‐Olaopa, E. Oluwabunmi, David K. Moscatello, E. Mackay, et al.. (2000). Evidence for the differential expression of a variant EGF receptor protein in human prostate cancer. British Journal of Cancer. 82(1). 186–194. 128 indexed citations
7.
Olapade‐Olaopa, E. Oluwabunmi, E. Mackay, Nick Taub, et al.. (1999). Malignant transformation of human prostatic epithelium is associated with the loss of androgen receptor immunoreactivity in the surrounding stroma.. PubMed. 5(3). 569–76. 79 indexed citations
8.
9.
10.
OSBORN, D. E., et al.. (1992). Tubulovillous adenoma arising 30 years after ileocystoplasty.. Journal of Clinical Pathology. 45(10). 928–929. 6 indexed citations
11.
Fletcher, Jack Μ., et al.. (1988). Class II HLA DNA polymorphisms in Type 1 (insulin-dependent) diabetic patients of North Indian origin. Diabetologia. 31(6). 343–350. 30 indexed citations
12.
Fletcher, Jack Μ., et al.. (1988). HLA-DR and DQ DNA polymorphisms in subjects of Asian Indian and white caucasian origin. Molecular Immunology. 25(4). 411–417. 9 indexed citations
13.
Young, I D, Raymond Dalgleish, E. Mackay, et al.. (1988). Discordant expression of the G syndrome in monozygotic twins. American Journal of Medical Genetics. 29(4). 863–869. 8 indexed citations
14.
Fletcher, Jack Μ., et al.. (1987). The HLA-D associations of Type 1 (insulin-dependent) diabetes in Punjabi Asians in the United Kingdom. Diabetologia. 30(8). 618–621. 18 indexed citations
15.
Feehally, John, David C. Wheeler, E. Mackay, R. K. Oldham, & John Walls. (1987). Recurrent Acute Renal Failure with Interstitial Nephritis Due to D-Penicillamine. Renal Failure. 10(1). 55–57. 4 indexed citations
16.
Bottazzo, Gian Franco, et al.. (1985). In Situ Characterization of Autoimmune Phenomena and Expression of HLA Molecules in the Pancreas in Diabetic Insulitis. New England Journal of Medicine. 313(6). 353–360. 720 indexed citations breakdown →
17.
Mackay, E., et al.. (1978). Structural basis for the changing physical properties of human pulmonary vessels with age.. Thorax. 33(3). 335–344. 66 indexed citations
18.
Banks, Jonathan C., et al.. (1978). The Physical Properties of Human Pulmonary Arteries and Veins. Clinical Science. 55(5). 477–484. 14 indexed citations
19.
Mackay, E., D Pickering, & W A Littler. (1977). Cardiac biopsy in childhood.. Archives of Disease in Childhood. 52(10). 785–789. 13 indexed citations
20.
Mackay, E., et al.. (1976). Cardiac biopsy in skeletal myopathy: Report of a case with myocardial mitochondrial abnormalities. The Journal of Pathology. 120(1). 35–42. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026